The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

ABOUT


In-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.

  Email Alert |   RSS Feed

Staff | Free Trial | Subscribe | Recent Headlines

Why Read START-UP?

START-UP is the premier source for business intelligence on the newest companies and emerging technologies. START-UP is dedicated to helping you find and accurately evaluate real business development, licensing, and investment opportunities more efficiently than you ever imagined possible. In every issue, you get intel on new and emerging technologies; business models; financing strategies; VC and other early stage funding sources; deal profiles; and even tech transfers.


Who Reads START-UP?

Top-level pharmaceutical and biotechnology business development executives use START-UP to evaluate future markets, identify and profit from venture opportunities, identify competitive threats and more. START-UP delivers profiles of leading-edge companies and technology, including the most important new trends, licensing deals, investment opportunities, business models, financing strategies, and abundant deals data. Use START-UP to evaluate opportunities and threats that will guide your business development strategy.


Subscribe to START-UP and Save 35%*

1 year subscription with 1 year archive access - CLICK HERE

Includes: Email newsletter with latest headlines, breaking news alerts, and access to START-UP — in-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.

Multiple users/site features: Contact our Sales Team at +1-212-520-2765 or PharmaNewsSales@informa.com.
*New business only.